Document is current
Any future updates will be listed below
-
Authors
Ferreira, Beatriz H.
Mazeda, Carolina
Dourado, Eduardo
Simões, João L.
Prata, Ana Rita
Argüello, Rafael J.
Duarte, Iola F.
Pierre, Philippe
Almeida, Catarina R.
-
Funding
Funding for this research was provided by:
World Scleroderma Foundation and Edith Busch Stiftung (EBF and WSF Research Grant Programme 2022-2023)
Fundação para a Ciência e a Tecnologia (UIDB/04501/2020, DOI 10.54499/UIDB/04501/2020, UIDP/04501/2020, DOI 10.54499/UIDP/04501/2020, UIDB/50011/2020 (DOI 10.54499/UIDB/50011/2020), UIDP/50011/2020 (DOI 10.54499/UIDP/50011/2020) & LA/P/0006/2020 (DOI 10.54499/LA/P/0006/2020))
Fundação para a Ciência e a Tecnologia ((LA/P/0008/202, DOI 10.54499/LA/P/0008/2020; UIDP/50006/2020, DOI 10.54499/UIDP/50006/2020; UIDB/50006/2020, DOI10.54499/UIDB/50006/2020))
- License Information
-
More Information
Article History
Received: 6 December 2024
Accepted: 6 February 2025
First Online: 19 February 2025
Declarations
:
: All participants signed an informed consent form before inclusion and clinical data collected were anonymised. This study was approved by the Ethics Committee of Centro Hospitalar do Baixo Vouga (now ULS-RA) (Reference 44-069-2021).
: Not applicable.
: Rafael J. Argüello is scientist and co-founder of GammaOmics, a startup that holds the exclusive license to commercialize and provide services for SCENITH™, a technology utilized in this study. No other conflicts of interest are declared.
